Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Sakuma

Showing results (201-210 of 257) with videos related to

Pageof 26
Sort By:
Shock (Augusta, Ga.)|May 21, 2020
Cardiac Variation of Internal Jugular Vein as a Marker of Volume Change in Hemorrhagic ShockKurato Tokunaga, Kensuke Nakamura, Ryota Inokuchi, et al.
Cardiovascular Diabetology|June 17, 2020
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapyMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 31, 2004
Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humansNaoyuki Matsuda, Subrina Jesmin, Yoshika Takahashi, et al.
Cancers|March 25, 2022
Correlation of Intraoperative 5-ALA-Induced Fluorescence Intensity and Preoperative <sup>11</sup>C-Methionine PET Uptake in Glioma SurgeryKazuhide Shimizu, Kaoru Tamura, Shoko Hara, et al.
Heart Rhythm|August 16, 2011
Regional cooling facilitates termination of spiral-wave reentry through unpinning of rotors in rabbit heartsMasatoshi Yamazaki, Haruo Honjo, Takashi Ashihara, et al.
Diabetes|July 19, 2013
Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemiaKwang Kon Koh, Soo Lim, Hanul Choi, et al.
Heart and Vessels|May 26, 2019
Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysisIchiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi, et al.
Heart and Vessels|August 4, 2019
Correction to: Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysisIchiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 15, 2010
Rate-dependent shortening of action potential duration increases ventricular vulnerability in failing rabbit heartMasahide Harada, Yukiomi Tsuji, Yuko S Ishiguro, et al.
Journal of Pharmacological Sciences|May 30, 2012
Pharmacological blockade of IKs destabilizes spiral-wave reentry under β-adrenergic stimulation in favor of its early terminationSara Kato, Haruo Honjo, Yoshio Takemoto, et al.
Pageof 26

Showing results (201-210 of 257) with videos related to

Sort By:
Pageof 26
Shock (Augusta, Ga.)|May 21, 2020
Cardiac Variation of Internal Jugular Vein as a Marker of Volume Change in Hemorrhagic ShockKurato Tokunaga, Kensuke Nakamura, Ryota Inokuchi, et al.
Cardiovascular Diabetology|June 17, 2020
Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapyMasato Furuhashi, Ichiro Sakuma, Takeshi Morimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 31, 2004
Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humansNaoyuki Matsuda, Subrina Jesmin, Yoshika Takahashi, et al.
Cancers|March 25, 2022
Correlation of Intraoperative 5-ALA-Induced Fluorescence Intensity and Preoperative <sup>11</sup>C-Methionine PET Uptake in Glioma SurgeryKazuhide Shimizu, Kaoru Tamura, Shoko Hara, et al.
Heart Rhythm|August 16, 2011
Regional cooling facilitates termination of spiral-wave reentry through unpinning of rotors in rabbit heartsMasatoshi Yamazaki, Haruo Honjo, Takashi Ashihara, et al.
Diabetes|July 19, 2013
Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemiaKwang Kon Koh, Soo Lim, Hanul Choi, et al.
Heart and Vessels|May 26, 2019
Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysisIchiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi, et al.
Heart and Vessels|August 4, 2019
Correction to: Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysisIchiro Sakuma, Shinichiro Uchiyama, Hirotsugu Atarashi, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 15, 2010
Rate-dependent shortening of action potential duration increases ventricular vulnerability in failing rabbit heartMasahide Harada, Yukiomi Tsuji, Yuko S Ishiguro, et al.
Journal of Pharmacological Sciences|May 30, 2012
Pharmacological blockade of IKs destabilizes spiral-wave reentry under β-adrenergic stimulation in favor of its early terminationSara Kato, Haruo Honjo, Yoshio Takemoto, et al.
Pageof 26